Prosecution Insights
Last updated: August 06, 2026
Application No. 17/761,622

WIRE MANAGEMENT COUPLER FOR A MEDICAL DEVICE

Final Rejection §102§112
Filed
Mar 18, 2022
Priority
Sep 20, 2019 — provisional 62/903,410 +1 more
Examiner
BERTRAM, ERIC D
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
St. Jude Medical
OA Round
2 (Final)
81%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
1043 granted / 1286 resolved
+11.1% vs TC avg
Moderate +13% lift
Without
With
+12.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
55 currently pending
Career history
1325
Total Applications
across all art units

Statute-Specific Performance

§101
4.1%
-35.9% vs TC avg
§103
36.0%
-4.0% vs TC avg
§102
29.6%
-10.4% vs TC avg
§112
12.5%
-27.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1286 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s amendments and associated arguments filed 6/29/2026 with respect to the previous 102 and 103 rejection of the claim have been fully considered and are persuasive. Therefore, the rejections have been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Buesseler et al. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 13-15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 13 has been amended to recite that the “first and second sensor grooves are configured to guide the connecting wires.” However, the original specification seems to make clear that is the first and second recessed areas that are configured to guide the connecting wires, as claimed. The claims state that the wires extend through the recessed areas and not the sensor grooves. Clarification is requested so that the metes and bounds of the claim are clear. Claims 14 and 15 depend from claim 13 and are indefinite based on their association. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 2 and 13-15 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Buesseler et al. (US 2018/0289356, hereinafter Buesseler). Regarding claims 1, 2 and 13, Buesseler discloses a catheter with a coupler (see abstract). The catheter comprises an elongate shaft defining a shaft longitudinal axis and including a proximal and distal end, with the coupler disposed within a distal end of the shaft (par. 0038). The coupler has a longitudinal axis and includes a first sensor groove 202 and a second sensor groove 204’ in an exterior surface of the coupler (see figures 2A-2E and par. 0053-0056). Sensor 202’ is placed withing sensor groove 202 and sensor 204 is placed within sensor groove 204’ (see figures 2A-2E and par. 0053-0056). A first recessed wire management feature and a second recessed wire management feature is located proximally to the first sensor groove and second sensor groove, respectively, each feature configured to guide connecting wires extending from the sensors toward the coupler longitudinal axis, such that as the wires follow the recessed features, they eventually end up ectending along the longitudinal axis of the coupler, as seen in figures 2A and 2E and in the annotated figure below: PNG media_image1.png 600 866 media_image1.png Greyscale Regarding claims 14 and 15, the catheter (i.e., a tube with a tubular lumen) is at the proximal end of the coupler, such that the wires extend out of the proximal end of the coupler and into the tubular lumen of the catheter tube (par. 0038). Allowable Subject Matter Claims 16-20 are allowed. Claims 3-12 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See attached PTO-892, specifically US 2008/0065002 (which discloses a catheter with wire management lumens) and US 2019/0038228 (see claim 14, disclosing a catheter with a proximal sensor coupler). Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eric D Bertram whose telephone number is (571)272-3446. The examiner can normally be reached Monday-Friday 8am-6pm Central Time. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Eric D. Bertram/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Mar 18, 2022
Application Filed
Apr 21, 2026
Non-Final Rejection mailed — §102, §112
Jun 12, 2026
Interview Requested
Jun 23, 2026
Applicant Interview (Telephonic)
Jun 23, 2026
Examiner Interview Summary
Jun 29, 2026
Response Filed
Jul 17, 2026
Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12697490
HYBRID MULTI-PHASIC STIMULATION
3y 9m to grant Granted Aug 04, 2026
Patent 12690934
POSITION CONTROL FOR PATIENT CONSOLE
3y 2m to grant Granted Jul 28, 2026
Patent 12691285
MEDICAL DEVICES, SYSTEMS, AND METHODS THAT ADJUST PHYSIOLOGICAL SIGNAL THRESHOLDS TO CONTROL STIMULATION THERAPY
3y 0m to grant Granted Jul 28, 2026
Patent 12667719
FORAMINA-FILLING IMPLANTABLE MEDICAL LEAD
2y 4m to grant Granted Jun 30, 2026
Patent 12661501
BIOSTIMULATOR HAVING RESILIENT SCAFFOLD
2y 4m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
81%
Grant Probability
94%
With Interview (+12.6%)
3y 2m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1286 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month